FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT07221032 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07221032
- Sponsor
- Medical College of Wisconsin
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2028-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.